Ellevest, Inc. Selecta Biosciences Inc Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	BUY	$0.67 - $1.4 $45 - $95	68 New	68 $0
Q4 2021 Jan 24, 2022	SELL	$2.89 - $4.43 $144 - $221	-50 Closed	0 $0
Q3 2021 Oct 19, 2021	BUY	$3.36 - $4.62 $168 - $231	50 New	50 $0
Q2 2021 Jul 13, 2021	SELL	$2.82 - $5.01 $95 - $170	-34 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$1.64 - $3.42 $55 - $116	34 New	34 $0

4.67M

Ticker SELB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 152,712,992
Market Cap $128M
Description
Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.